Patent · US Active

Modulators of sphingosine phosphate receptors

US8466183B2 · kind B2 · utility

9Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 6, 2012
Grant dateJun 18, 2013
Priority date
Expiry dateSep 6, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the following generic structure are provided:Such compounds activate a sphingosine-I-phosphate receptor of the subtype 1 (S1P1), and have utility in the treatment of malconditions mediated by S1P1 activation. More specifically, such compounds are beneficial in the treatment of, for example, multiple sclerosis, transplant rejection and/or adult respiratory syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.